[1] 杨智, 吴伟刚, 欧鹏程, 等. 成人EBV感染临床特点及发生噬血细胞综合征的预测因素[J/CD]. 新发传染病电子杂志, 2022, 7(2):35-40. [2] SYLVESTER JE, BUCHANAN BK, SILVA TW.Infectious Mononucleosis:Rapid Evidence Review[J]. Am Fam Physician, 2023, 107(1):71-78. [3] 黄南, 凌科技, 李湘胜. CRP,PCT,PLR,PDW联合诊断传染性单核细胞增多症合并细菌感染[J]. 湖南师范大学学报:医学版, 2023, 20(2):120-125. [4] 马艺文, 谭继超, 张宇, 等. 新抑癌基因INPP4B在EB病毒相关胃癌中的表达及其临床意义[J]. 中国医科大学学报, 2019, 48(7):587-590. [5] NAUGHTON P, HEALY M, ENRIGHT F, et al.Infectious Mononucleosis:diagnosis and clinical interpretation[J]. Br J Biomed Sci, 2021, 78(3):107-116. [6] WADÉ NB, CHANG CM, CONTI D, et al.InterLymph Consortium Immunology and Infection Working Group. Infectious mononucleosis, immune genotypes, and non-Hodgkin lymphoma (NHL):an InterLymph Consortium study[J]. Cancer Causes Control, 2020, 31(5):451-462. [7] YANG Y, HUA CZ.Multianatomical site EBV DNA testing could facilitate the diagnosis of infectious mononucleosis in children-Comment on "Diagnostic value of serological and molecular biological tests for infectious mononucleosis by EBV in different age stages and course of disease"[J]. J Med Virol,2021,93(11):6077-6078. [8] 任高伟, 刘灵, 李明丽, 等. 长疗程抗病毒治疗对传染性单核细胞增多症患儿EBV抑制的影响[J]. 药物生物技术, 2019, 26(6):516-520. [9] 张耀文, 史春雷, 费海荣, 等. EB病毒特异性细胞毒T淋巴细胞治疗复发难治性NK/T细胞淋巴瘤(鼻型)1例报告并文献复习[J]. 青岛大学学报(医学版), 2021, 57(5):777-779. [10] 胡亚美, 江载芳. 诸福棠实用儿科学[M]. 7版. 北京:人民卫生出版, 2002:819-827. [11] ITO Y, SUZUKI M, KAWADA J, et al.Diagnostic values for the viral load in peripheral blood mononuclear cells of patients with chronic active Epstein-Barr virus disease[J]. J Infect Chemother,2016,22(4):268-271. [12] CAI L, XING Y, XIA Y, et al.Comparative study of biomarkers for the early identification of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in infectious mononucleosis[J]. BMC Infect Dis, 2023, 23(1):728. [13] LIU M, WANG X, ZHANG L, et al.Epidemiological characteristics and disease burden of infectious mononucleosis in hospitalized children in China:A nationwide retrospective study[J]. Virol Sin, 2022, 37(5):637-645. [14] 张静静, 贾媛媛, 胡苗苗, 等. 传染性单核细胞增多症肝损害患儿血清ADA,LDH及EBV DNA水平对评估病情及预后的临床价值[J].川北医学院学报, 2023, 38(8):1090-1093. [15] MALHI H, HOMAD LJ, WAN YH, et al.Immunization with a self-assembling nanoparticle vaccine displaying EBV gH/gL protects humanized mice against lethal viral challenge[J]. Cell Rep Med,2022,3(6):100658. [16] 魏雪梅, 周燕清, 邓继岿. 静脉注射免疫球蛋白治疗儿重症传染性单核细胞增多症2例[J]. 儿科药学杂志, 2022, 28(11):65-66. [17] SHI T, HUANG L, TIAN J.Prevalence of Epstein-Barr Viral DNA among children at a single hospital in Suzhou, China[J]. J Pediatr (Rio J),2022,98(2):142-146. [18] DOWELL AC, HAIGH TA, RYAN GB, et al.Cytotoxic CD4+ T-cells specific for EBV capsid antigen BORF1 are maintained in long-term latently infected healthy donors[J]. PLoS Pathog, 2021, 17(12):e1010137. [19] CHEN B, HAN N, GAO LY, et al.Comparison of immune responses in children with infectious mononucleosis caused by Epstein-Barr virus at different infection stages[J]. Int J Lab Hematol,2023,45(6):890-898. [20] 黄婷婷, 郑武田, 刘梦莹, 等. 传染性单核细胞增多症患儿NLR,CD4^(+)/CD8^(+)比值,ADA与EBV DNA载量的相关性分析及对肝损害的影响[J]. 现代生物医学进展, 2023, 23(7):1340-1344. [21] PRICOCO R, MEIDEL P, HOFBERGER T, et al.One-year follow-up of young people with ME/CFS following infectious mononucleosis by Epstein-Barr virus[J]. Front Pediatr,2024,11(5):1266738. [22] LIU M, WANG R, XIE Z.T cell-mediated immunity during Epstein-Barr virus infections in children[J]. Infect Genet Evol,2023,112(6):105443. [23] 韩冬梅, 乐原. 传染性单核细胞增多症患儿EB病毒DNA载量与免疫指标及白细胞计数和血沉水平相关性分析[J]. 陕西医学杂志, 2022, 51(7):882-885. |